Suppliers / Jiangsu Kingshan New Material

Jiangsu Kingshan New Material

China Updated 9 July 2026

Jiangsu Kingshan New Material is an API manufacturer based in China. It holds 2 active US drug master files across a filed portfolio of 2 molecules.

2
active US DMFs
0
valid CEPs
0
registered plants
0
filings across 0 regulators

What they file, and where

Molecule Regulators Docs
Calcium US FDA 1
Cholestyramine US FDA 1

Also appears on these molecule pages

Cholestyramine API

Questions about Jiangsu Kingshan New Material

Does Jiangsu Kingshan New Material hold a US DMF or a CEP?
Jiangsu Kingshan New Material holds 2 active US drug master files. A drug master file is a submission to the FDA describing how an ingredient is made; a CEP is the EDQM's certificate that the substance meets its European Pharmacopoeia monograph. Both are filings rather than approvals.
What does Jiangsu Kingshan New Material make?
2 molecules are on record against Jiangsu Kingshan New Material, including Calcium and Cholestyramine. Each links through to that molecule's full manufacturer list.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Jiangsu Kingshan New Material comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Ion Exchange (India) shares 1 molecule Purolite shares 1 molecule Phaex Polymers shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability